Walmart EVP Daniel J. Bartlett sells 3,990 shares of stock
Daniel J. Bartlett, Walmart's EVP, sells 3,990 shares of company stock, reflecting ongoing trends in executive stock management and transparency.
Moritz Robert Edward Jr. Reports Share Acquisition from Walmart
Moritz Robert Edward Jr. has reported acquiring 361 shares of Walmart as part of his director compensation, reflecting ongoing practices in the retail industry.
Mehrotra Shishir Receives Shares as Director Compensation
Mehrotra Shishir received 277 shares of Walmart as quarterly director compensation, increasing his total holdings. This reflects trends in retail executive compensation.
Bakkt CEO Receives 243,454 Restricted Stock Units Grant
Naheta Akshay Sudhir, CEO of Bakkt, Inc., has been granted 243,454 RSUs, reflecting the company's commitment to leadership retention in finance services.
Friar Sarah reports director compensation transaction with Walmart
Friar Sarah discloses a transaction of 337 shares of Walmart Inc. as part of director compensation, emphasizing corporate governance transparency.
Mayer reports stock transaction as Walmart director
Marissa A. Mayer reports a stock transaction as part of her director compensation at Walmart, reflecting ongoing engagement in the retail sector.
Walmart director Carla A. Harris receives 168 shares as pay
Carla A. Harris, director at Walmart, received 168 shares in quarterly compensation, reflecting corporate governance practices in the retail sector.
Fung exercises stock options, acquires shares in Cardio Diagnostics
Peter K. Fung exercises stock options, acquiring shares in Cardio Diagnostics Holdings, reflecting confidence in the company's future growth.
Stephenson reports share transaction at Walmart Inc.
Randall L. Stephenson reports a transaction of 457 shares in Walmart, reflecting his commitment to the company and its strategic direction.
Pretti Luiz Antonio Dos Santos acquires stock units in PACCAR
Pretti Luiz Antonio Dos Santos acquires 193.2872 stock units in PACCAR, signaling continued confidence in the company's performance.
Ramaswamy Sreeganesh reports stock unit acquisition at PACCAR
Ramaswamy Sreeganesh reports acquisition of stock units at PACCAR, impacting corporate governance and investor relations in the automotive industry.
Walton Steuart L reports share transaction with Walmart Inc.
Walton Steuart L discloses a transaction of 337 shares of Walmart Inc., reflecting ongoing director compensation arrangements in the retail sector.
Pigott John Reports Changes in PACCAR Stock Ownership
John Pigott discloses changes in his PACCAR stock ownership, highlighting his role as a director and potential impacts on the company's governance.
Real REMAX Group amends stock ownership filing for accuracy
Real REMAX Group Inc. corrects stock transaction dates in an amended filing, enhancing transparency in ownership disclosures.
Ticho Barry Sells 1,051 Shares of Stoke Therapeutics Stock
Ticho Barry, CMO of Stoke Therapeutics, sold 1,051 shares of common stock, reflecting management activity in the pharmaceutical sector.
Breber Pierre R Reports Stock Transactions in PACCAR Inc
Breber Pierre R disclosed stock transactions involving PACCAR Inc, indicating changes in ownership dynamics within the automotive manufacturing sector.
America's Car-Mart CEO Reports Stock Transaction
Douglas W. Campbell Jr. of America's Car-Mart reports a stock transaction involving nearly 5,000 shares, reflecting ongoing executive compensation adjustments.
GCT Semiconductor director acquires shares through RSUs
GCT Semiconductor's director Jeffrey Tuder acquires 12,971 shares through restricted stock units, reflecting the company's compensation strategy.
Penner Gregory Boyd reports share transaction for Walmart
Penner Gregory Boyd disclosed a transaction of 547 shares of Walmart Inc. as part of his director compensation, reflecting ongoing ties to the retail giant.
Venker Executes Major Stock Transactions at Roivant Sciences
Eric Venker, CEO of Immunovant, has made significant stock transactions involving Roivant Sciences, reflecting strategic management in the pharmaceutical sector.